Antihemophilic factor (recombinant), PEGylated Recruiting Phase 4 Trials for Hemophilia A / prophylaxis of Bleeding Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT05036278
Prophylaxis Regimen for Hemophilia A Patients